Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiopaque etonogestrel implant contraception study
ACTRN12607000556448Phase 3Active, not recruiting
- Sponsor
- Organon & Co.
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 4
01
Overview
Phase 3, open-label, single-arm trial of etonogestrel in contraception, sponsored by Organon & Co. Started Apr 2007; status: active, not recruiting.
02
Drugs
etonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on ACTRN12607000556448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000556448.